TITLE

BAYER SUBMITS VARDENAFIL NDA FOR ERECTILE FUNCTION

PUB. DATE
November 2001
SOURCE
Worldwide Biotech;Nov2001, Vol. 13 Issue 11, p7
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on Bayer Corporation's submission of a New Drug Application for vardenafil, an investigational compound for the improvement of erectile function, to the United States Food and Drug Administration.
ACCESSION #
5457847

 

Related Articles

  • PFIZER BOOSTS LIPITOR'S SAFETY.  // Medical Marketing & Media;Oct2001, Vol. 36 Issue 10, p36 

    Focuses on the promotional activities of Bayer Corp. to increase consumer awareness about the safety of Lipitor in the U.S.

  • German shops vie for Alka Seltzer.  // Adweek Western Edition;2/27/95, Vol. 45 Issue 9, p14 

    Reports on German agencies that are vying for an advertising account for Bayer's Alka Seltzer brand.

  • 5 Shops Pitch New Bayer Brand. McMains, Andrew // Adweek Western Edition;8/19/2002, Vol. 52 Issue 34, p4 

    Focuses on the contention among advertising agencies in the U.S. for the account of Bayer Corporation's Ascensia brand which helps diabetics test their glucose levels. Estimated value of the account; Marketing and advertising components of the account; Number of agencies competing for the account.

  • NEW DOSAGE.  // Drug Topics;9/4/2000, Vol. 144 Issue 17, p48 

    Presents information on the drugs Baycol (cerivastatin sodium tablets) from Bayer Corp. and hydrocodone bitartrate and acetaminophen tablets from Mallinckrodt Inc. Drug indications; Recommended dosage.

  • Product news.  // Medical Marketing & Media;Jul99, Vol. 34 Issue 7, p21 

    Reports on the approval of the drug to treat hypercholesteremia from Bayer Corp.

  • 5 Shops Pitch New Bayer Brand. McMains, Andrew // Adweek Midwest Edition;8/19/2002, Vol. 43 Issue 34, p4 

    Reports that several shops have presented strategic concepts for a brand from Bayer Corp. that helps diabetics test their glucose levels. Estimated amount of billings; Responsibility of the selected agency; Agency that handles the main over the counter brands from Bayer.

  • Bayer's Bacteria. Mokhiber, Russell // Multinational Monitor;Apr2001, Vol. 22 Issue 4, p29 

    Reports that public interest groups called on the Bayer Corp. to end its opposition to the proposed ban on the use of fluoroquinolones antibiotic in the United States. Challenges and arguments posed by Bayer against the proposed ban; Role of fluoroquinolones in antibiotic resistance; Factors...

  • Bayer rebuked for ED claims.  // Medical Marketing & Media;Aug2001, Vol. 36 Issue 8, p28 

    Reports on the violation incurred by Bayer Corp. on promoting vardenafil, a investigational treatment for erectile dysfunction in the U.S. Citation of the Federal Food, Drug and Cosmetic Act; Report made by the Division of Drug Marketing, Advertising, and Communications; Demand for immediate...

  • PRODUCT NEWS.  // Medical Marketing & Media;Jun2001, Vol. 36 Issue 6, p22 

    Reports developments related to drug development in the U.S. as of June 2001. Approval on the use of Bayer Corporation's Avelox for treatment of uncomplicated skin and skin structure; Release of STAARVISC II, an injectable opthalmic viscoelastic product from Anika Therapeutics Inc.; Components...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics